Lumexa Imaging (LMRI.US) IPO prices at $18.50 per share, aiming to raise $463 million.

American diagnostic imaging service provider Lumexa Imaging Holdings (LMRI.US) issued 25 million shares at a price of $18.50 per share, raising $4.63 billion, with pricing within the offering range of $17 to $20 per share. The company's market value will reach $1.8 billion after listing, with an enterprise value of $2.6 billion. Lumexa is a national provider of outpatient diagnostic imaging services in the United States, operating 184 imaging centers in 13 states through wholly-owned sites and joint ventures with healthcare systems. The company offers a range of advanced and routine imaging equipment including MRI, CT, PET scans, X-rays, ultrasound, and mammography. In the 12 months ending September 30, 2025, the company achieved sales of $1 billion. Lumexa Imaging Holdings plans to list on the NASDAQ under the stock symbol "LMRI". The joint bookrunners for this offering include Barclays, JPMorgan, Jefferies Financial Group Inc., Deutsche Bank Aktiengesellschaft, Wells Fargo & Company Securities, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, and Raymond James.